Repurposed Retroviruses

B cells have commandeered ancient viral sequences in the genome to transmit antigen signals.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

B cellWIKIMEDIA, BRUCEBLAUSRetroviral sequences in mammalian genomes are the remnants of old viral infections and, for the most part, their expression is suppressed. But a report published today (December 18) in Science suggests that, in B cells, a particular type of antigen can stimulate transcription of these viral relics, which in turn prompts cell proliferation and antibody production.

The work is a “tour de force,” said Michael Cancro, a professor of pathology and laboratory medicine at the University of Pennsylvania Perelman School of Medicine who was not involved in the study. “It may well be the seminal paper in resolving this long-standing conundrum of exactly what is a TI-2 antigen doing to get these B cells to kick off.”

TI-2 antigens are so named because they can stimulate B cells to produce antibodies in a T cell-independent (TI) manner. Unlike protein antigens—which need T helper cells to interact with and stimulate the B cell in which they are being processed—TI antigens can stimulate B cells on their own. TI-2 antigens tend to be large polysaccharides with repetitive structures, such as those that encapsulate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies